Formulation and development of paediatric orally disintegrating carbamazepine tablets
Carbamazepine is a medicine used to manage epilepsy and partial or tonic-clonic seizures. This study aimed at formulating and obtaining carbamazepine orodispersible tablets for paediatric use at a 50 mg dose, with a diameter not greater than 6 mm and a tablet weight of 80 mg, through a direct compre...
Saved in:
Main Authors: | R Canadell-Heredia (Author), M Suñé-Pou (Author), A Nardi-Ricart (Author), P Pérez-Lozano (Author), JM Suñé-Negre (Author), E García-Montoya (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a Carvedilol Oral Liquid Formulation for Paediatric Use
by: Blanca Chiclana-Rodríguez, et al.
Published: (2023) -
Robustness Optimization of an Existing Tablet Coating Process Applying Retrospective Knowledge (rQbD) and Validation
by: Albert Galí, et al.
Published: (2020) -
Palatability and Stability Studies to Optimize a Carvedilol Oral Liquid Formulation for Pediatric Use
by: Blanca Chiclana-Rodríguez, et al.
Published: (2023) -
Excipients in the Paediatric Population: A Review
by: Khadija Rouaz, et al.
Published: (2021) -
Application of Galenic Strategies for Developing Gastro-Resistant Omeprazole Formulation for Pediatrics
by: Khadija Rouaz-, et al.
Published: (2024)